Source:http://linkedlifedata.com/resource/pubmed/id/19616583
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1-3
|
pubmed:dateCreated |
2009-10-13
|
pubmed:abstractText |
Parathyroid hormone-related protein (PTHrP) is expressed by human colon cancer tissue and cell lines; expression correlates with colon carcinoma severity. PTHrP is synthesized as a prepro isoform and contains two targeting sequences - a signal sequence and a nuclear localization signal (NLS). The signal peptide (SP) directs PTHrP to the secretory pathway, where it exerts autocrine/paracrine effects. The NLS directs PTHrP to the nucleus/nucleolus, where it exerts intracrine effects. In this study, we used the human colon cancer cell line LoVo as a model system to study the effects of autocrine/paracrine and intracrine PTHrP action on cell growth and survival, hallmarks of malignant tumor cells. We report that PTHrP increases cell growth and survival, protects cells from serum-starvation-induced apoptosis, and promotes anchorage-independent cell growth via an intracrine pathway. Conversely, autocrine/paracrine PTHrP action decreases cell growth and survival. We also show an inverse relationship between secreted and nuclear PTHrP levels, in that cells overexpressing NLS-deleted PTHrP secrete higher PTHrP levels than those overexpressing the wild-type isoform. Conversely, SP deletion results in higher nuclear PTHrP levels. These observations provide evidence of a link between intracrine PTHrP action and cell growth and survival. Targeting PTHrP production in colon cancer may thus prove therapeutically beneficial.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
1873-1686
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:day |
27
|
pubmed:volume |
158
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
149-55
|
pubmed:dateRevised |
2011-3-3
|
pubmed:meshHeading |
pubmed-meshheading:19616583-Apoptosis,
pubmed-meshheading:19616583-Cell Division,
pubmed-meshheading:19616583-Cell Line, Tumor,
pubmed-meshheading:19616583-Cell Nucleus,
pubmed-meshheading:19616583-Cell Survival,
pubmed-meshheading:19616583-Gene Silencing,
pubmed-meshheading:19616583-Humans,
pubmed-meshheading:19616583-Parathyroid Hormone-Related Protein,
pubmed-meshheading:19616583-Polymerase Chain Reaction,
pubmed-meshheading:19616583-Signal Transduction
|
pubmed:year |
2009
|
pubmed:articleTitle |
Nuclear PTHrP targeting regulates PTHrP secretion and enhances LoVo cell growth and survival.
|
pubmed:affiliation |
Department of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, TX 77555, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, N.I.H., Extramural
|